Cost-effectiveness of early detection of atrial fibrillation via remote control of implanted devices

Journal of Evaluation in Clinical Practice

Volumn 20, Issue 5, 2014, Pages 570-577

  Lorenzoni, Giulia ^a   Folino, Franco ^a   Soriani, Nicola ^a   Iliceto, Sabino ^a   Gregori, Dario ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Evaluation; Health economics; Health services research

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRIC ACID DERIVATIVE; SOTALOL;

AGED; AMBULATORY CARE; ARTICLE; ATRIOVENTRICULAR BLOCK; BODY MASS; BRADYCARDIA; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; ELECTROCARDIOGRAM; ELECTROGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MONTE CARLO METHOD; NATIONAL HEALTH SERVICE; PACEMAKER; PRIMARY PREVENTION; PRIORITY JOURNAL; REMOTE CONTROL; REMOTE SENSING; RISK REDUCTION; SECONDARY PREVENTION; SICK SINUS SYNDROME; ADVERSE EFFECTS; AMBULATORY MONITORING; ARTIFICIAL HEART PACEMAKER; ATRIAL FIBRILLATION; COMPLICATION; DEVICES; ECONOMICS; INCIDENCE; MIDDLE AGED; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; COST-BENEFIT ANALYSIS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MONITORING, AMBULATORY; MONTE CARLO METHOD; PACEMAKER, ARTIFICIAL; STROKE;

EID: 84927789018     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/jep.12132     Document Type: Article

References (26)

1. Lloyd-Jones, D. M., Wang, T. J., Leip, E. P., et al. (2004) Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation, 110(9), 1042-1046.
2. Heeringa, J., van der Kuip, D. A., Hofman, A., Kors, J. A., van Herpen, G., Stricker, B. H., Stijnen, T., Lip, G. Y. & Witteman, J. C. (2006) Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. European Heart Journal, 27(8), 949-953.
3. Orlov, M. V., Ghali, J. K., Araghi-Niknam, M., Sherfesee, L., Sahr, D. & Hettrick, D. A. (2007) Asymptomatic atrial fibrillation in pacemaker recipients: incidence, progression, and determinants based on the atrial high rate trial. Pacing and Clinical Electrophysiology: PACE, 30(3), 404-411.
4. Defaye, P., Dournaux, F. & Mouton, E. (1998) Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA study. The AIDA Multicenter Study Group. Automatic Interpretation for Diagnosis Assistance. Pacing and Clinical Electrophysiology: PACE, 21(1 Pt 2), 250-255.
5. Benjamin, E. J., Wolf, P. A., D'Agostino, R. B., Silbershatz, H., Kannel, W. B. & Levy, D. (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation, 98(10), 946-952.
6. Wolf, P. A., Abbott, R. D. & Kannel, W. B. (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke; a Journal of Cerebral Circulation, 22(8), 983-988.
7. Capucci, A., Santini, M., Padeletti, L., et al. (2005) Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. Journal of the American College of Cardiology, 46(10), 1913-1920.
8. Israel, C. W., Gronefeld, G., Ehrlich, J. R., Li, Y. G. & Hohnloser, S. H. (2004) Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. Journal of the American College of Cardiology, 43(1), 47-52.
9. Lamassa, M., Di Carlo, A., Pracucci, G., et al. (2001) Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project). Stroke; a Journal of Cerebral Circulation, 32(2), 392-398.
10. Ricci, R. P., Morichelli, L. & Santini, M. (2009) Remote control of implanted devices through Home Monitoring technology improves detection and clinical management of atrial fibrillation. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 11(1), 54-61.
11. Ricci, R. P., Morichelli, L. & Santini, M. (2008) Home monitoring remote control of pacemaker and implantable cardioverter defibrillator patients in clinical practice: impact on medical management and health-care resource utilization. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 10(2), 164-170.
12. Brugada, P. (2006) What evidence do we have to replace in-hospital implantable cardioverter defibrillator follow-up? Clinical Research in Cardiology, 95(3), III-3-III-9.
13. Raatikainen, M. J., Uusimaa, P., van Ginneken, M. M., Janssen, J. P. & Linnaluoto, M. (2008) Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 10(10), 1145-1151.
14. Lazarus, A. (2007) Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database. Pacing and clinical electrophysiology: PACE, 30(Suppl. 1), S2-S12.
15. Burri, H. & Senouf, D. (2009) Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 11(6), 701-709.
16. Varma, N., Stambler, B. & Chun, S. (2005) Detection of atrial fibrillation by implanted devices with wireless data transmission capability. Pacing and clinical electrophysiology: PACE, 28(Suppl. 1), S133-S136.
17. Folino, A. F., Breda, R., Calzavara, P., Migliore, F., Iliceto, S. & Buja, G. (2012) In-home controls of pacemakers in debilitated elderly patients. Geriatrics & Gerontology International, 12(1), 30-35.
18. Folino, A. F., Breda, R., Calzavara, P., Borghetti, F., Comisso, J., Iliceto, S. & Buja, G. (2013) Remote follow-up of pacemakers in a selected population of debilitated elderly patients. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 15(3), 382-387.
19. Proclemer, A., Ghidina, M., Gregori, D., Facchin, D., Rebellato, L., Zakja, E., Gulizia, M. & Esente, P. (2010) Trend of the main clinical characteristics and pacing modality in patients treated by pacemaker: data from the Italian Pacemaker Registry for the quinquennium 2003-07. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 12(2), 202-209.
20. VOSE Software (2013) Model Risk.
21. Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N. & Conde, J. G. (2009) Research electronic data capture (REDCap) - a metadatadriven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377-381.
22. R Development Core Team (2012) R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
23. Varma, N., Epstein, A. E., Irimpen, A., Schweikert, R. & Love, C. (2010) Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST). Trial Circulation, 122(4), 325-332.
24. Ricci, R. P., Morichelli, L., Gargaro, A., Laudadio, M. T. & Santini, M. (2009) Home monitoring in patients with implantable cardiac devices: is there a potential reduction of stroke risk? Results from a computer model tested through Monte Carlo simulations. Journal of Cardiovascular Electrophysiology, 20(11), 1244-1251.
25. Andrew, N. E., Thrift, A. G. & Cadilhac, D. A. (2013) The prevalence, impact and economic implications of atrial fibrillation in stroke: what progress has been made? Neuroepidemiology, 40(4), 227-239.
26. Hart, R. G., Benavente, O., McBride, R. & Pearce, L. A. (1999) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Annals of Internal Medicine, 131(7), 492-501.